Successful treatment with bortezomib in combination with dexamethasone in a middle-aged male with idiopathic multicentric Castleman’s disease: A case report
Multicentric Castleman disease (MCD) is a heterogeneous, life-threatening disease. A subgroup of HIV-negative and HHV-8-negative MCD is defined as idiopathic MCD (iMCD) with a poor prognosis. Here we report an unusual case of a 47-year-old male patient with iMCD who experienced multiple treatment re...
Main Authors: | Li Hongling, He Yang, Wang Yongying, Xu Mengwei |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2024-01-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0763 |
Similar Items
-
Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease
by: Asami Nishikori, et al.
Published: (2022-09-01) -
Idiopathic multicentric Castleman’s disease
by: V. I. Vasilyev, et al.
Published: (2020-06-01) -
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
by: Bernardo Rossini, et al.
Published: (2024-03-01) -
Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports
by: Simone Ferrero, et al.
Published: (2021-03-01) -
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
by: Yu-han Gao, et al.
Published: (2024-03-01)